NCT07008742View on ClinicalTrials.gov

Feasibility Study of Tissue and Blood Collection in Oncogene-addicted and Neoadjuvantly Treated Non Small Cell Lung Cancer

RecruitingOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

June 4, 2025

Primary Completion Date

June 1, 2029

Study Completion Date

June 1, 2029

Conditions
Oncogene-addicted Non Small Cell Lung CancerEarly-stage Operable Non Small Cell Lung CancerNon Small Cell Lung CancerMetastatic Non Small Cell Lung CancerLocally Advanced NSCLC - Non-Small Cell Lung CancerStage 2/3 Operable Non Small Cell Lung Cancer
Trial Locations (1)

SW3 6JJ

RECRUITING

The Royal Marsden NHS Foundation Trust, London

All Listed Sponsors
collaborator

Francis Crick Institute

OTHER

collaborator

University of Cambridge

OTHER

collaborator

Royal Brompton & Harefield NHS Foundation Trust

OTHER

collaborator

Institute of Cancer Research, United Kingdom

OTHER

lead

Royal Marsden NHS Foundation Trust

OTHER

NCT07008742 - Feasibility Study of Tissue and Blood Collection in Oncogene-addicted and Neoadjuvantly Treated Non Small Cell Lung Cancer | Biotech Hunter | Biotech Hunter